ASCO Daily News

Nathan A. Pennell, MD, PhD, discusses notable lung cancer abstracts from the 2017 ASCO Annual Meeting.

Susana M. Campos, MD, MPH, provides an update on PARP inhibitors for ovarian cancer.

George D. Demetri, MD, discusses the evolving treatment landscape of advanced soft tissue sarcoma.

Steven E. Finkelstein, MD, discusses the latest recommendations from the prostate cancer RADAR II Working Group.

Roy S. Herbst, MD, PhD, provides updates on immunotherapy for cancer treatment.

ASCO Daily News Editor-in-Chief John Sweetenham, MD, FRCP, FACP, discusses notable hematology abstracts from the 2017 ASCO Annual Meeting.

Experts recap key takeaways from the SWOG Spring Group Meeting.

In this podcast from the ASCO Educational Book, Don S. Dizon, MD, FACP, interviews Dr. Mary Sabatini, MD, PhD, about pertinent health issues for women with BRCA mutations.

Dr. Catherine Lai, of the National Heart, Lung, and Blood Institute at the National Institutes of Health, discusses new immunotherapies aimed at decreasing relapse rates in patients with leukemia.

Dr. Catherine Lai, of the National Heart, Lung, and Blood Institute at the National Institutes of Health, discusses new immunotherapies aimed at decreasing relapse rates in patients with leukemia.

Dr. Heather McArthur, medical director of breast oncology at Cedars-Sinai Medical Center, discusses combination radiotherapy/immunotherapy treatments aimed at increasing survival outcomes of patients with breast cancer that has metastasized to the brain.

Dr. Tito Fojo discusses the treatment of adrenocortical cancer in adult and pediatric patients with the disease.

Dr. Matthew J. Resnick of Vanderbilt University School of Medicine discusses the role of advanced cancer screening in more guided surgical treatment of patients with prostate cancer.

Dr. Cathy Eng discusses disparities in both treatment and outcomes for colorectal cancer, among other topics.

Dr. Gilberto Lopes discusses preventative medicine in GI Cancers, including for international patients with cancer.

Dr. Beverly Moy discusses research presented at the 2016 ASCO Annual Meeting as her expectations for future studies in the specialty of breast cancer.

Dr. Edward Garon discusses research presented at the 2016 ASCO Annual Meeting as his expectations for future studies in the specialty of lung cancer.

Dr. Julie Brahmer discusses the process of managing toxicities associated with immunotherapy treatment for lung cancer.

Dr. Nathan Pennell previews the current state of lung-cancer research and previews the 2016 ASCO Annual Meeting.

Dr. John Sweetenham previews some of the top sessions at this year's Annual Meeting covering the latest topics in Hematology